| 标题 |
 Rezivertinib versus gefitinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer (REZOR): a multicentre, double-blind, randomised, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet. Respiratory medicine 作者：Shi Y; Guo Y; Li X; Wu L; Chen Z; et al 出版日期：2025/04/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
Nole
秋风
cdercder
Wells
Kao
Sapphire
dew
无极微光
DW
Syening
Anonymous
聊赠一枝春
Rita
悦耳的怀寒
dawnfrf
OK
if
善良的采蓝
luli
皖公网安备34019202002308
